Your browser doesn't support javascript.
loading
Exploration of prognostic factors of castration-resistant prostate cancer patients / 中草药
Chinese Traditional and Herbal Drugs ; (24): 5882-5888, 2018.
Article Dans Chinois | WPRIM | ID: wpr-851486
ABSTRACT
Objective To investigate the prognostic factors of castrated resistant prostate cancer (CRPC). Methods From December 1, 2015 to November 30, 2017, CRPC patients who met the inclusion criteria were collected from the First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tumor Hospital of Tianjin Medical University, and General Hospital of Tianjin Medical University. The reliability and validity of 18 included factors were analyzed. The Kaplan-Meier method was used to screen the prognostic factors of CRPC and draw the survival curve.The significant fators from single factor analysis were included in COX proportional risk model for multiple-factor analysis to determine the independent prognostic factors. Results Hematuria, osteodynia, HGB 5.18 mmol/L, TPSA > 10 ng/mL, f/tPSA > 0.19, deficiency of both qi and blood, and no treatment of combination of traditional Chinese medicine were the risk factors for overall survival (OS) in CRPC patients; CHO > 5.18 mmol/L was the only risk factor for OS in CRPC patients, which was established as risk factors. CHO > 5.18 mmol/L, HGB 5.18 mmol/L is an independent risk factor for OS in CRPC patients.

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Type d'étude: Étude pronostique / Facteurs de risque langue: Chinois Texte intégral: Chinese Traditional and Herbal Drugs Année: 2018 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Type d'étude: Étude pronostique / Facteurs de risque langue: Chinois Texte intégral: Chinese Traditional and Herbal Drugs Année: 2018 Type: Article